Scientists from Johns Hopkins Medicine say they have found a treatment that can actually satisfy a ceaseless itch: cannabis.
New research from scientists at Temple University suggests that KLS-13019, an analog of CBD, may be even more promising for long-term pain management than CBD itself.
Effective from Friday May 7, 2021, US researchers are now required to measure and report results using the unit in all studies involving THC and human subjects.
The report also highlights an urgent need to reform the rules governing hemp farming, including the current ban on harvesting the plant material for CBD extraction.
Cannabis groups are once again highlighting the need for reform in the UK cannabis industry, following the release of a new report from Maple Tree Consultants and Mackrell Solicitors.
Steep Hill Labs, a multi-state cannabis testing company, has announced that it will soon operate in the US state of Mississippi.
The study of patient data found that less than 40 percent of medical cannabis patients over the age 50 have had such discussions with their doctor.
A new technology developed by researchers at the University of California Davis promises to fast-track the development of compounds that could exploit psychedelics’ therapeutic action without hallucinogenic side effects.
Scientists at Syracuse University have demonstrated that CBD users benefit both from the psychological expectation and the real pharmacological effects of the drug.